Search Results for "Recall Promus Heart Stent"

04:00 EDT 17th August 2017 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...


Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Failure HF

Heart Transplantation

Matching News

Diabetes control tied to heart stent outcomes

(Reuters Health) - For people with type 2 diabetes, maintaining good blood sugar control in the years after receiving a coronary artery stent is associated with a lower risk of heart attack and stroke...

OrbusNeich File Patent Infringement Lawsuit Against Boston Scientific in Ireland

FORT LAUDERDALE, Fla., March 8, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and its subsidiary, Orbus International B.V., (collectively, "OrbusNeich") today announced that they have commenced a paten...

Curbside Heart Risk; Ear Lobes and Stroke; Heart Pump Recall

(MedPage Today) -- Recent developments of interest in cardiovascular medicine

Stent Retriever Recall; Rush Hour Pollution; Maternal Death

(MedPage Today) -- Recent developments of interest in cardiovascular medicine

Detroit hospital treats first high-risk patient with Tryton stent

St. John Hospital & Medical Center became the first facility in the United States to treat a high-risk patient with a heart pump and newly approved Tryton Side Branch Stent.

FDA Clears Medtronic's Resolute Onyx Drug-Eluting Stent

With the first 4.5-mm and 5.0-mm drug-eluting stent sizes available in the US, the stent expands treatment options for patients with large coronary anatomies. FDA Approvals

India government panel rejects Boston Scientific plea on stent price caps

NEW DELHI (Reuters) - Boston Scientific Corp stands to lose millions of dollars on its high-end heart stent in India after a government panel rejected its request to increase a cap on the price that ...

Q1 2017 Pharma Recall Trends

ArticleStericycle Expert Solutions publishes quarterly Recall Index, revealing first quarter recall trends in the pharmaceutical space.

Matching PubMed Articles

Search Whole site using Google

Quick Search
Advertisement Advertisement